CUE NASDAQ
Cue Biopharma, Inc.
1W: -18.6%
1M: -5.2%
3M: -21.3%
YTD: +152.7%
1Y: +17.8%
3Y: -65.1%
5Y: -94.1%
$25.57
+0.32 (+1.27%)
Weekly Expected Move ±18.5%
$16
$21
$26
$30
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$38M
Revenue
+354.4% YoY
$-164M
Net Income
-321.9% YoY
$-50M
Free Cash Flow
-77.1% YoY
99.5%
Gross Margin
-1113.3%
Op. Margin
-1943.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-1603.5%
ROA-459.6%
ROIC1241.9%
Valuation
P/E-0.9
P/B70.2
EV/EBITDA-2.0
Leverage
Debt/Equity3.81
Current Ratio1.25
Interest Cov.-726.7x
Quality Scores
Piotroski F3/9
Altman Z-28.89
Beneish M-15.62